Palo Alto, CANCT05783817Now EnrollingIRB Ready

Obsessive-Compulsive Disorder Clinical Trial in Palo Alto, CA

Access cutting-edge obsessive-compulsive disorder treatment through this phase 2 clinical trial at a research site in Palo Alto. Study-provided care at no cost to qualified participants.

Sponsored by Carolyn Rodriguez

Quick Self-Assessment

See if you qualify for this Palo Alto location

Preparing your pre-screening questions…

Expert Care in Palo Alto

Access obsessive-compulsive disorder specialists at no cost

IRB Approved

This study follows strict safety protocols and ethical guidelines

No-Cost Care

All study-related obsessive-compulsive disorder treatment provided free

Apply for This Palo Alto Location

Check if you qualify for this obsessive-compulsive disorder clinical trial in Palo Alto, CA

Secure & Confidential

Your information is protected and will only be shared with the research team.

Why Participate?

  • No-Cost Study Care

  • Local to Palo Alto

    Convenient for CA residents

  • Cutting-Edge Treatment

    Access to innovative therapies

  • Expert Medical Care

    Close monitoring by specialists

  • Possible Compensation*

    For time and travel

*Compensation varies by study. Confirm details with coordinator.

Simple Process

  1. 1Submit this form
  2. 2Phone screening
  3. 3Visit Palo Alto site if eligible
  4. 4Begin participation

About This Obsessive-Compulsive Disorder Study in Palo Alto

The study assesses the safety and preliminary effectiveness of MDMA-assisted cognitive behavioral therapy in participants diagnosed with obsessive-compulsive disorder (OCD).

Sponsor: Carolyn Rodriguez

Who Can Participate

Inclusion Criteria

At least 18 years old
Fluent in speaking and reading the predominantly used or recognized language of the study site
Able to swallow pills
Meet the criteria for OCD diagnosis
YBOCS total score of at least 16
Not on psychotropic medications 1 month prior to study enrollment
Able to tolerate a treatment-free period
Able to tolerate study procedures
Failed at least 1 prior trial of standard first-line OCD treatment
Agree to the following lifestyle modifications: comply with requirements for fasting and refraining from certain medications prior to the Experimental Session, not enroll in any other interventional clinical trials during the duration of the study, and commit to medication dosing, therapy, and study procedures.

Exclusion Criteria

Pregnant or nursing, or able to become pregnant and are not practicing an effective means of birth control
Weigh less than 48 kilograms (kgs)
Any current problem which, in the opinion of the investigator or study physician, might interfere with participation

Not sure if you qualify? Submit your interest and a study coordinator will help determine your eligibility.

Frequently Asked Questions

Q:Is this study available in Palo Alto?

Yes, this clinical trial (NCT05783817) has an active research site in Palo Alto, CA that is currently enrolling participants.

Q:Is it safe to participate?

Clinical trials follow strict safety guidelines and ethical standards. This study has been reviewed and approved, and participants are closely monitored by medical professionals. You can withdraw at any time.

Q:Will I be compensated?

Many clinical trials offer compensation for your time and travel expenses. Specific compensation details will be discussed during the screening process. All study-related medical care is provided at no cost.

Q:Can I leave the trial if I change my mind?

Absolutely. Participation is completely voluntary. You have the right to withdraw from the study at any time, for any reason, without penalty.

Still have questions? Our study coordinators are here to help.

Obsessive-Compulsive Disorder Treatment Options in Palo Alto, CA

If you're searching for obsessive-compulsive disorder treatment options in Palo Alto, CA, this clinical trial (NCT05783817) may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.

Our Palo Alto research site is actively enrolling participants for this phase 2 clinical trial. You'll receive care from experienced obsessive-compulsive disorder specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.

Looking for more options? Browse all obsessive-compulsive disorder clinical trials near you to find additional studies recruiting in your area.

More OCD Trials in Palo Alto, CA

See all ocd clinical trials recruiting in Palo Alto — not just this study.

Browse OCD Trials in Palo Alto →

Browse More Trials by Condition

OCD TrialsAll Conditions →

Ready to Join in Palo Alto?

Take the first step toward participating in this groundbreaking clinical trial

Secure · Expert Care · Palo Alto, CA